Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pro Dex (PDEX) Other Non-Current Liabilities (2020 - 2022)

Historic Other Non-Current Liabilities for Pro Dex (PDEX) over the last 3 years, with Q1 2022 value amounting to $1.2 million.

  • Pro Dex's Other Non-Current Liabilities changed N/A to $1.2 million in Q1 2022 from the same period last year, while for Mar 2022 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $397000.0 for FY2021, which is 5062.19% down from last year.
  • As of Q1 2022, Pro Dex's Other Non-Current Liabilities stood at $1.2 million.
  • Pro Dex's Other Non-Current Liabilities' 5-year high stood at $1.2 million during Q1 2022, with a 5-year trough of $397000.0 in Q2 2021.
  • In the last 3 years, Pro Dex's Other Non-Current Liabilities had a median value of $804000.0 in 2020 and averaged $813000.0.
  • Within the past 5 years, the most significant YoY rise in Pro Dex's Other Non-Current Liabilities was 5062.19% (2021), while the steepest drop was 5062.19% (2021).
  • Over the past 3 years, Pro Dex's Other Non-Current Liabilities (Quarter) stood at $804000.0 in 2020, then rose by 23.26% to $991000.0 in 2021, then grew by 17.46% to $1.2 million in 2022.
  • Its last three reported values are $1.2 million in Q1 2022, $991000.0 for Q4 2021, and $709000.0 during Q3 2021.